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BACKGROUND:
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Hyperphosphatemia is a common condition found 
in patients with decreased kidney function.  Without 
treatment, it can lead to a variety of clinical 
consequences. The presence of hyperphosphatemia 
in patients with normal kidney function may be 
true or spurious. We present a case of pseudo 
hyperphosphatemia in a patient with multiple myeloma. 
CASE REPORT:
60 year female with a history of Multiple myeloma in 
remission was admitted with back pain. She was noted 
to have sodium of 128mmol/l, phosphorus of 12.6mg/dl, 
calcium 9mg/dl and creatinine of 1mg/dl by labs done 
with Siemens Advia through spectrophotometry. She had 
no clinical manifestations of hyperphosphatemia and her 
serum osmolality was found to be normal. With normal 
creatinine, calcium, low sodium and normal osmolality we 
had suspicion of spurious results from paraproteinemia. 
So, same sample was rechecked on dry chemistry 
analyzer (Vitros). Barium sulfate spreading layer in the 
Vitros dry chemistry slide filters the protein in serum 
and assays phosphate in a protein free filtrate negating 
interference of paraproteins. Patients repeat sodium and 
phosphorus on the same blood sample was 137mmol/l 
and 4.8mg/dl.
DISCUSSION:
Spurious elevation of the serum phosphorus 
level may occur in with prolonged refrigeration, 
prolonged exposure to room temperature, hemolysis, 
hyperlipidemia, hyperbilirubinemia or paraproteinemia. 
Ourpatient’s initial sample was tested using a clinical 
analyzer in which inorganic phosphorus reacts with 
ammonium molybdate in the presence of sulfuric 
acidto form an unreduced phosphomolybdate complex.
This phosphomolybdate complex absorbs light and 
is quantified photometrically in the UV range at a 
wavelength of 340 nm. Light absorbance is directly 
proportional to the inorganic phosphorus concentration.
Two mechanisms have been hypothesized to explain 
pseudohyperphosphatemia. First, paraproteins bind to 
RESULT:
Pseudohyperphosphatemia in the presence of serum 
paraproteins has been documented but the paucity of 
case reports reflect the scant attention clinicians routinely 
pay to phosphate measurements. Clinicians taking 
care of patients with myeloma need to be aware of the 
potential interference in phosphate-measuring assays 
that can result in spurious values to prevent unnecessary 
tests and starting the patient on a phosphate binder 
which can lead to dangerously low levels of phosphorus 
with spurious normal readings.
molybdate, resulting in turbidity. The turbid reactionmixture 
scatters and absorbs light while reducing its transmittance. 
This then can be interpreted as a falsely high phosphorus 
level. The second proposed mechanism for spurious 
hyperphosphatemia is the direct binding of paraprotein 
to phosphorus. This interference is seen with the liquid 
colorimetric assay on the Advia is not seen with the slide-
based, solid-state colorimetric assays on the Vitros In our 
case, spurious hyperphosphatemia caused by hemolysis, 
hyperlipidemia and hyperbilirubinemia was excluded. 
Siemens Advia 1800 Analyser Vitros - 350 Analyser
